Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 5-6/2020

23.01.2020 | original article

Linking myeloperoxidase with subclinical atherosclerosis in adults with metabolic syndrome

verfasst von: MD, PhD Andreea Iana, MD, PhD Elena Sirbu

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Backround

Myeloperoxidase (MPO) is a leukocyte-derived enzyme that has been associated with cardiovascular diseases in many studies. Together with hydrogen peroxide and a halogen, MPO forms a very strong antimicrobial system and there is evidence of links between MPO and inflammation in cardiovascular diseases. Brachial flow-mediated dilation (FMD) refers to a physiologic measure, and carotid intima-media thickness (IMT) is an anatomic structural measure of subclinical atherosclerosis. This research aimed to assess the correlation of MPO serum levels with subclinical atherosclerosis in patients with metabolic syndrome (MS) using the parameters FMD and IMT.

Methods

A total of 88 patients with metabolic syndrome defined according to the International Diabetes Criteria (IDF) criteria were recruited in the study. Doppler ultrasound was used to determine the left and right common carotid artery thickness (left and right CCA IMT) and FMD of brachial artery. The MPO concentrations were measured using the Immundiagnostik MPO ELISA kit.

Results

A significant inverse correlation between MPO and brachial FMD (r = −0.354, p < 0.001), a significant positive correlation between MPO and right CCA IMT (r = 0.327, p < 0.001), and a significant positive correlation between MPO and left CCA IMT (r = 0.301, p < 0.001) in patients with MS were obtained in this research study.

Conclusion

Serum MPO concentration is correlated with subclinical atherosclerosis in patients with MS. The MPO may be a potential therapeutic goal in patients with MS. This finding suggests that new biological markers for MS and subclinical atherosclerosis are helpful for understanding the mechanisms of the risk factors and their role as a considerable burden on the population.
Literatur
1.
Zurück zum Zitat Fattahi MR, Niknam R, Safarpour A, Sepehrimanesh M, Lotfi M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis. 2016;8(2):131–7. CrossRef Fattahi MR, Niknam R, Safarpour A, Sepehrimanesh M, Lotfi M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis. 2016;8(2):131–7. CrossRef
2.
Zurück zum Zitat Cuspidi C, Sala C, Provenzano F, Tadic M, Gherbesi E, Grassi G, et al. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2018;36(1):23–30. CrossRef Cuspidi C, Sala C, Provenzano F, Tadic M, Gherbesi E, Grassi G, et al. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2018;36(1):23–30. CrossRef
3.
Zurück zum Zitat Ronald JA. Imaging myeloperoxidase activity in cardiovascular disease. Curr Cardiovasc Imaging Rep. 2011;4:24–31. CrossRef Ronald JA. Imaging myeloperoxidase activity in cardiovascular disease. Curr Cardiovasc Imaging Rep. 2011;4:24–31. CrossRef
4.
Zurück zum Zitat Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48–60. CrossRef Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48–60. CrossRef
5.
Zurück zum Zitat Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015;3:175–88. CrossRef Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015;3:175–88. CrossRef
6.
Zurück zum Zitat Papageorgiou N, et al. Imaging subclinical atherosclerosis: where do we stand? Curr Cardiol Rev. 2017;13(1):47–55. CrossRef Papageorgiou N, et al. Imaging subclinical atherosclerosis: where do we stand? Curr Cardiol Rev. 2017;13(1):47–55. CrossRef
7.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A, et al. The task force for the management of arterial hypertension of the European sociey of hypertension (ESH) and of the European society of cardiology (ESC). 2007 guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–536. PubMed Mancia G, De Backer G, Dominiczak A, et al. The task force for the management of arterial hypertension of the European sociey of hypertension (ESH) and of the European society of cardiology (ESC). 2007 guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–536. PubMed
8.
Zurück zum Zitat Koohi-Hosseinabadi O, Andisheh-Tadbir A, Bahadori P, Sepehrimanesh M, Mardani M, Tanideh N. Comparison of the therapeutic effects of the dietary and topical forms of zizyphus jujuba extract on oral mucositis induced by 5‑fluorouracil: a golden hamster model. J Clin Exp Dent. 2015;7(2):e304. CrossRef Koohi-Hosseinabadi O, Andisheh-Tadbir A, Bahadori P, Sepehrimanesh M, Mardani M, Tanideh N. Comparison of the therapeutic effects of the dietary and topical forms of zizyphus jujuba extract on oral mucositis induced by 5‑fluorouracil: a golden hamster model. J Clin Exp Dent. 2015;7(2):e304. CrossRef
9.
Zurück zum Zitat Mardani M, Afra SM, Tanideh N, Andisheh Tadbir A, Modarresi F, Koohi-Hosseinabadi O, et al. Hydroalcoholic extract of carum carvi L. in oral mucositis: a clinical trial in male golden hamsters. Oral Dis. 2016;22(1):39–45. CrossRef Mardani M, Afra SM, Tanideh N, Andisheh Tadbir A, Modarresi F, Koohi-Hosseinabadi O, et al. Hydroalcoholic extract of carum carvi L. in oral mucositis: a clinical trial in male golden hamsters. Oral Dis. 2016;22(1):39–45. CrossRef
10.
Zurück zum Zitat Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, et al. Healing acceleration of acetic acid-induced colitis by marigold (calendula officinalis) in male rats. Saudi J Gastroenterol. 2016;22(1):50. CrossRef Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, et al. Healing acceleration of acetic acid-induced colitis by marigold (calendula officinalis) in male rats. Saudi J Gastroenterol. 2016;22(1):50. CrossRef
11.
Zurück zum Zitat Cires-Drouet RS, et al. Imaging of high-risk carotid plaques: ultrasound. Semin Vasc Surg. 2017;30(1):44–53. CrossRef Cires-Drouet RS, et al. Imaging of high-risk carotid plaques: ultrasound. Semin Vasc Surg. 2017;30(1):44–53. CrossRef
12.
Zurück zum Zitat Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015;13:4. CrossRef Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015;13:4. CrossRef
13.
Zurück zum Zitat Daiber A, Steven S, Weber A, Shuvaev VV, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–619. CrossRef Daiber A, Steven S, Weber A, Shuvaev VV, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–619. CrossRef
14.
Zurück zum Zitat Velarde GP, Sherazi S, Kraemer DF, Bravo-Jaimes K, Butterfield R, Amico T, et al. Clinical and biochemical markers of cardiovascular structure and function in women with the metabolic syndrome. Am J Cardiol. 2015;116(11):1705–10. CrossRef Velarde GP, Sherazi S, Kraemer DF, Bravo-Jaimes K, Butterfield R, Amico T, et al. Clinical and biochemical markers of cardiovascular structure and function in women with the metabolic syndrome. Am J Cardiol. 2015;116(11):1705–10. CrossRef
15.
Zurück zum Zitat Vita JA, Brennan ML, Gokce N, Mann SA. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110(9):1134–9. CrossRef Vita JA, Brennan ML, Gokce N, Mann SA. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110(9):1134–9. CrossRef
16.
Zurück zum Zitat van der Zwan LP, Teerlink T, Dekker JM, et al. Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism. Metabolism. 2010;59:1723–9. CrossRef van der Zwan LP, Teerlink T, Dekker JM, et al. Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism. Metabolism. 2010;59:1723–9. CrossRef
17.
Zurück zum Zitat Sawicki M, Sypniewska G, Kozinski M, et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Eur J Clin Invest. 2011;41:667–71. CrossRef Sawicki M, Sypniewska G, Kozinski M, et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Eur J Clin Invest. 2011;41:667–71. CrossRef
18.
Zurück zum Zitat Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk prospective population study. J Am Coll Cardiol. 2007;50(2):159–65. CrossRef Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk prospective population study. J Am Coll Cardiol. 2007;50(2):159–65. CrossRef
19.
Zurück zum Zitat Zaugg M, Lucchinetti E. Remote ischemic preconditioning in cardiac surgery—ineffective and risky? N Engl J Med. 2015;373:1470–2. CrossRef Zaugg M, Lucchinetti E. Remote ischemic preconditioning in cardiac surgery—ineffective and risky? N Engl J Med. 2015;373:1470–2. CrossRef
Metadaten
Titel
Linking myeloperoxidase with subclinical atherosclerosis in adults with metabolic syndrome
verfasst von
MD, PhD Andreea Iana
MD, PhD Elena Sirbu
Publikationsdatum
23.01.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-019-01602-y